The main objective of the said acquisition is due to company’s interest in the Pharmaceutical and Allied sector in line with the proposed objects of the company
The company has purchased all the shares in Evagrace Pharma on March 27, 2019
The Board of the company at their meeting held on February 25, 2019, approved the same
The subsidiaries are formed to further the company's interest in the Pharmaceutical and Allied sector in line with the proposed objects of the company
Price feed provided by www.nseindia.com
and www.bseindia.com value
addition by www.accordfintech.com.
Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided " as is" and solely for informational
purposes, not for trading purposes or advice, and may be delayed.